Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Nov 27, 2020; 12(11): 908-918
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.908
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.908
Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis
Saroja Bangaru, Internal Medicine, Gastroenterology, University of California at Los Angeles, Los Angeles, CA 90025, United States
Jihane N Benhammou, The Vatche and Tamar Manoukian Division of Digestive Diseases, University of California at Los Angeles, Los Angeles, CA 90095, United States
James H Tabibian, Department of Medicine, Olive View-University of California at Los Angeles Medical Center, Sylmar, CA 91342, United States
James H Tabibian, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
Author contributions: Bangaru S drafted the manuscript; Benhammou JN provided critical revision of the manuscript; Tabibian JH provided supervision and critical revisions; all authors approved the submitted manuscript.
Conflict-of-interest statement: No potential conflicts of interest, no financial support.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: James H Tabibian, MD, PhD, FACP, Health Sciences Clinical Associate Professor, Department of Medicine, Olive View-University of California at Los Angeles Medical Center, 14445 Olive View Drive, 2B-182, Sylmar, CA 91342, United States. jtabibian@dhs.lacounty.gov
Received: June 24, 2020
Peer-review started: June 24, 2020
First decision: July 30, 2020
Revised: August 13, 2020
Accepted: September 10, 2020
Article in press: September 10, 2020
Published online: November 27, 2020
Peer-review started: June 24, 2020
First decision: July 30, 2020
Revised: August 13, 2020
Accepted: September 10, 2020
Article in press: September 10, 2020
Published online: November 27, 2020
Core Tip
Core Tip: Because the population of patients with compensated advanced chronic liver disease continues to grow, it is neither beneficial nor cost-effective to perform endoscopic variceal screening in all patients. Therefore, there is ongoing research into the development of methods to non-invasively risk stratify patients with cirrhosis for the presence of high risk esophageal varices and effectively limit the population that undergoes endoscopic variceal screening. These topics are reviewed in this article.